Alternatively, while there was a slight decrease in CD45+ cells in the VI in SB225002-treated tumor-bearing animals compared to vehicle-treated tumor-bearing animals, this difference was not significant (Figure 4D). This evidence concerns the gene PTPRC and neoplasm.